Using PSMA PET/CT to assess response in metastatic prostate cancer (mPC) patients (pts) receiving upfront chemohormonal therapy

被引：0
|
作者：
Anton, A. [1 ]
Ballok, Z. [2 ]
Bowden, P. [3 ]
Costello, T. [4 ,5 ]
Harewood, L. [4 ,7 ]
Corcoran, N. [4 ,5 ]
Dundee, P. [4 ,5 ]
Peters, J. [4 ]
Lawrentschuk, N. [6 ,8 ]
Troy, A. [6 ]
Webb, D. [6 ]
Chan, Y. [6 ]
See, A. [3 ]
Siva, S. [3 ,9 ]
Murphy, D. [8 ]
Hofman, M. S. [10 ]
Tran, B. [1 ,6 ,11 ]
机构：
[1] Walter & Eliza Hall Inst Med Res, Syst Biol & Personalised Med, Melbourne, Vic, Australia
[2] Healthcare Imaging Serv, Nucl Med, Melbourne, Vic, Australia
[3] ICON Canc Care, Radiat Oncol, Melbourne, Vic, Australia
[4] Royal Melbourne Hosp, Urol, Melbourne, Vic, Australia
[5] Australian Prostate Ctr, Melbourne, Vic, Australia
[6] Epworth Healthcare, Urol, Melbourne, Vic, Australia
[7] Univ Melbourne, Dept Surg, Melbourne, Vic, Australia
[8] Peter MacCallum Canc Ctr, Urol, Melbourne, Vic, Australia
[9] Peter MacCallum Canc Ctr, Radiat Oncol, Melbourne, Vic, Australia
[10] Peter MacCallum Canc Ctr, Nucl Med, Melbourne, Vic, Australia
[11] Peter MacCallum Canc Ctr, Med Oncol, Melbourne, Vic, Australia
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
223P
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Response Evaluation Criteria in PSMA PET/CT (RECIP 1.0) in Metastatic Castration-resistant Prostate Cancer
    Gafita, Andrei
    Djaileb, Loic
    Rauscher, Isabel
    Fendler, Wolfgang P.
    Hadaschik, Boris
    Rowe, Steven P.
    Herrmann, Ken
    Calais, Jeremie
    Rettig, Matthew
    Eiber, Matthias
    Weber, Manuel
    Benz, Matthias R.
    Farolfi, Andrea
    RADIOLOGY, 2023, 308 (01)
  • [22] Utilizing ChatGPT for assessing disease volume in patients (pts) with metastatic prostate cancer (mPC).
    Garg, Micah
    Ostrowski, Micah
    Srivastava, Ayana
    Chigarira, Beverly
    Jo, Yeonjung
    Ozay, Zeynep Irem
    Hage Chehade, Chadi
    Gebrael, Georges
    Sayegh, Nicolas
    Fortuna, Gliceida Galarza
    Mathew Thomas, Vinay
    Maughan, Benjamin L.
    Swami, Umang
    Agarwal, Neeraj
    Li, Haoran
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL)
  • [23] Cytoreductive radical prostatectomy after chemohormonal therapy in patients with primary metastatic prostate cancer
    Christa Babst
    Thomas Amiel
    Tobias Maurer
    Sophie Knipper
    Lukas Lunger
    Robert Tauber
    Margitta Retz
    Kathleen Herkommer
    Matthias Eiber
    Gunhild von Amsberg
    Markus Graefen
    Juergen Gschwend
    Thomas Steuber
    Matthias Heck
    Asian Journal of Urology, 2022, (01) : 69 - 74
  • [24] Role of Ga-68-PSMA PET/CT in recurring and metastatic prostate cancer
    Kulkarni, H.
    Wester, H. -J.
    Baum, R. P.
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56
  • [25] Use of PSMA PET/CT to detect prostate cancer metastatic to a preexisting thyroid nodule
    Chalker, Cameron
    Yilmaz, Burcak
    Trone, Kristin
    Parecki, Genevieve
    Chen, Athena
    Lim, James Y.
    Mallak, Nadine
    Sokolova, Alexandra O.
    NPJ PRECISION ONCOLOGY, 2024, 8 (01)
  • [26] Irreversible electroporation for prostate cancer using PSMA PET-CT
    Shin, Dongho
    Yoon, Chang Eil
    Kwon, Hyeok Jae
    Park, Yong Hyun
    Cho, Hyuk Jin
    Ha, U-syn
    Hong, Sung-Hoo
    Park, Sonya Youngju
    Ha, Seunggyun
    O, Joo Hyun
    Yoo, Ie Ryung
    Park, Chansoo
    Chi, Dae Yoon
    Lee, Ji Youl
    PROSTATE INTERNATIONAL, 2023, 11 (01) : 40 - 45
  • [27] Cytoreductive radical prostatectomy after chemohormonal therapy in patients with primary metastatic prostate cancer
    Babst, Christa
    Amiel, Thomas
    Maurer, Tobias
    Knipper, Sophie
    Lunger, Lukas
    Tauber, Robert
    Retz, Margitta
    Herkommer, Kathleen
    Eiber, Matthias
    von Amsberg, Gunhild
    Graefen, Markus
    Gschwend, Juergen
    Steuber, Thomas
    Heck, Matthias
    ASIAN JOURNAL OF UROLOGY, 2022, 9 (01) : 69 - 74
  • [28] The Impact of Baseline PSMA PET/CT Versus CT on Outcomes of 223Ra Therapy in Metastatic Castration-Resistant Prostate Cancer Patients
    Bosch, Dianne
    van der Velden, Kim J. M.
    Oving, Irma M.
    Wyndaele, Dirk N. J.
    Weijs, Leo E.
    van Schelven, W. Dick
    Oyen, Wim J. G.
    Beek, Erik T. te
    van de Luijtgaarden, Addy C. M.
    Somford, Diederik M.
    Nagarajah, James
    Hermsen, Rick
    Mehra, Niven
    Gerritsen, Winald R.
    Doelen, Maarten J. van der
    van Oort, Inge M.
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65 (04) : 541 - 547
  • [29] Baseline PSMA PET/CT parameters predict overall survival and treatment response in metastatic castration-resistant prostate cancer patients
    Kleiburg, Fleur
    de Geus-Oei, Lioe-Fee
    Spijkerman, Romy
    Noortman, Wyanne A.
    van Velden, Floris H. P.
    Manohar, Srirang
    Smit, Frits
    Toonen, Frank A. J.
    Luelmo, Saskia A. C.
    van der Hulle, Tom
    Heijmen, Linda
    EUROPEAN RADIOLOGY, 2025,
  • [30] Consensus statements on PSMA PET/CT response assessment criteria in prostate cancer
    Stefano Fanti
    Karolien Goffin
    Boris A Hadaschik
    Ken Herrmann
    Tobias Maurer
    Steven MacLennan
    Daniela E. Oprea-Lager
    Wim JG Oyen
    Olivier Rouvière
    Nicolas Mottet
    Anders Bjartell
    European Journal of Nuclear Medicine and Molecular Imaging, 2021, 48 : 469 - 476
12345